Naldoxxa (Naloxone Hydrochloride, Oxycodone Hydrochloride)

Naldoxxa acts on opioid pathways to provide both analgesia and overdose reversal.

• Moderate to severe pain: delivers oxycodone‑mediated analgesia for patients needing strong pain control.
• Opioid overdose reversal: naloxone component rapidly displaces opioids at receptors to restore normal respiration.
• Post‑operative pain management: used when balanced analgesia and safety monitoring are required.

• Naloxone Hydrochloride competitively blocks mu, kappa and delta opioid receptors, displacing opioid agonists and reversing their effects. Oxycodone Hydrochloride binds as a mu‑opioid receptor agonist, activating intracellular pathways that inhibit nociceptive transmission, producing analgesia. The combined formulation allows simultaneous provision of analgesic effect and the capacity for rapid reversal if excessive opioid activity occurs.

Adverse reactions may vary depending on the relative contribution of each component.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Constipation: reduced bowel motility typical of opioid therapy.
• Dizziness: transient light‑headedness.
• Headache: mild cranial discomfort.

Serious or Rare Side Effects

• Respiratory depression: severe reduction in breathing, especially if oxycodone dose is high.
• Severe hypotension: marked drop in blood pressure.
• Seizures: rare neurologic events.
• Allergic reactions: rash, itching, or anaphylaxis.
• Cardiac arrhythmia: irregular heart rhythm.

Careful assessment and monitoring are essential when using a combined opioid antagonist/analgesic.

• Assess opioid tolerance: ensure patient has appropriate prior exposure.
• Monitor respiratory status: watch for signs of depression or improvement.
• Avoid use in severe hepatic impairment: metabolism may be altered.
• Use caution during pregnancy: potential fetal risk, discuss with obstetrician.
• Avoid concomitant CNS depressants: increased sedation risk.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Naldoxxa may interact with several medication classes, requiring vigilance.

Major Interactions (Avoid)

• Other opioid antagonists: may negate analgesic effect of oxycodone.
• MAO inhibitors: risk of hypertensive crisis when combined.
• CNS depressants (e.g., barbiturates): additive respiratory depression.

Moderate Interactions (Monitor Closely)

• Benzodiazepines: enhanced sedation and dizziness.
• Alcohol: increased central nervous system depression.
• CYP3A4 inhibitors (e.g., ketoconazole): may raise oxycodone plasma levels.